Abstract
Background: Rheumatoid arthritis (RA) involves persistent synovial inflammation together with progressive cartilage damage and bone erosion. Fibroblast-like synoviocytes (FLS) and macrophages are abundant in the inflamed synovium, but how their interactions contribute to matrix-destructive responses is less well defined. Methods: We integrated public bulk and single-cell transcriptomic analyses with experimental validation in collagen-induced arthritis (CIA) tissues to investigate inflammatory, redox-associated, and matrix-remodeling alterations in the RA synovial microenvironment. Bioinformatic analyses, intercellular communication modeling, histological assessment, enzyme-linked immunosorbent assay (ELISA), and immunoblotting were subsequently performed to characterize stromal–immune interactions and Nuclear factor erythroid 2-related factor 2 (NRF2)-associated signaling changes. Results: Single-cell analysis identified synovial immune-cell populations and predicted interactions between fibroblast-like synoviocytes (FLS) and macrophages. CellChat analysis identified extracellular matrix- and inflammatory-associated pathways, including POSTN–integrin and macrophage migration inhibitory factor (MIF)-related signaling, in FLS-to-macrophage communication. Bulk transcriptomic analyses showed higher expression of matrix metallopeptidase 3 (MMP3) and matrix metallopeptidase 13 (MMP13) in RA synovial tissue. RA synovial tissues exhibited elevated expression of matrix metallopeptidase 3 (MMP3) and matrix metallopeptidase 13 (MMP13), while RA macrophages showed increased oxidative stress-associated transcriptional signatures. In CIA rats, increased expression of NRF2-associated antioxidant proteins was accompanied by parallel reduced synovial inflammation and decreased MMP3 and MMP13 expression. Conclusions: These findings suggest that stromal–immune interactions in RA may involve altered macrophage redox regulation associated with matrix-degrading responses. NRF2-associated pathways may therefore contribute to the coordination of inflammatory and tissue-destructive processes in RA.